BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16041051)

  • 1. Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils.
    Baishanbo A; Gargala G; Delaunay A; François A; Ballet JJ; Favennec L
    Infect Immun; 2005 Aug; 73(8):5252-5. PubMed ID: 16041051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptosporidium hominis: experimental challenge of healthy adults.
    Chappell CL; Okhuysen PC; Langer-Curry R; Widmer G; Akiyoshi DE; Tanriverdi S; Tzipori S
    Am J Trop Med Hyg; 2006 Nov; 75(5):851-7. PubMed ID: 17123976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
    Tarazona R; Blewett DA; Carmona MD
    Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum.
    Yang S; Benson SK; Du C; Healey MC
    J Parasitol; 2000 Aug; 86(4):884-7. PubMed ID: 10958482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.
    Baishanbo A; Gargala G; Duclos C; François A; Rossignol JF; Ballet JJ; Favennec L
    J Antimicrob Chemother; 2006 Feb; 57(2):353-5. PubMed ID: 16361328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human cryptosporidiosis and Cryptosporidium spp. in Haiti].
    Raccurt CP; Brasseur P; Verdier RI; Li X; Eyma E; Stockman CP; Agnamey P; Guyot K; Totet A; Liautaud B; Nevez G; Dei-Cas E; Pape JW
    Trop Med Int Health; 2006 Jun; 11(6):929-34. PubMed ID: 16772015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the infectivity and pathogenicity of Cryptosporidium avium provides new information on parasitic sites within the host.
    Cui Z; Song D; Qi M; Zhang S; Wang R; Jian F; Ning C; Zhang L
    Parasit Vectors; 2018 Sep; 11(1):514. PubMed ID: 30231919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
    Kim HC; Healey MC
    J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectivity of gastric and intestinal Cryptosporidium species in immunocompetent Mongolian gerbils (Meriones unguiculatus).
    Kvác M; Sak B; Kvetonová D; Secor WE
    Vet Parasitol; 2009 Jul; 163(1-2):33-8. PubMed ID: 19394145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of UV-induced thymine dimers in individual Cryptosporidium parvum and Cryptosporidium hominis oocysts by immunofluorescence microscopy.
    Al-Adhami BH; Nichols RA; Kusel JR; O'Grady J; Smith HV
    Appl Environ Microbiol; 2007 Feb; 73(3):947-55. PubMed ID: 17012589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice.
    Yang S; Healey MC; Du C
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):141-5. PubMed ID: 8731022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults.
    Okhuysen PC; Chappell CL; Crabb JH; Sterling CR; DuPont HL
    J Infect Dis; 1999 Oct; 180(4):1275-81. PubMed ID: 10479158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.
    Surl CG; Kim HC
    J Vet Sci; 2006 Mar; 7(1):47-51. PubMed ID: 16434849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptosporidium parvum biliary tract infection in adult immunocompetent and immunosuppressed mice.
    Verdon R; Polianski J; Grodet A; Garry L; Carbon C
    J Med Microbiol; 1998 Jan; 47(1):71-7. PubMed ID: 9449952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum.
    Sheoran A; Wiffin A; Widmer G; Singh P; Tzipori S
    J Infect Dis; 2012 Mar; 205(6):1019-23. PubMed ID: 22279124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calves as a potential reservoir of Cryptosporidium parvum and Giardia sp.
    Bednarska M; Bajer A; Siński E
    Ann Agric Environ Med; 1998; 5(2):135-8. PubMed ID: 9860815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus).
    Gargala G; François A; Favennec L; Rossignol JF
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2821-3. PubMed ID: 23478972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of patent infection in immunosuppressed C57Bl/6 mice with a single Cryptosporidium meleagridis oocyst.
    Huang K; Akiyoshi DE; Feng X; Tzipori S
    J Parasitol; 2003 Jun; 89(3):620-2. PubMed ID: 12880270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health sequelae of human cryptosporidiosis in immunocompetent patients.
    Hunter PR; Hughes S; Woodhouse S; Raj N; Syed Q; Chalmers RM; Verlander NQ; Goodacre J
    Clin Infect Dis; 2004 Aug; 39(4):504-10. PubMed ID: 15356813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.